These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 16574718)

  • 1. Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users.
    Bedi G; Redman J
    J Psychopharmacol; 2006 May; 20(3):432-6. PubMed ID: 16574718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problematic versus non-problematic ecstasy/MDMA use: the influence of drug usage patterns and pre-existing psychiatric factors.
    Soar K; Turner JJ; Parrott AC
    J Psychopharmacol; 2006 May; 20(3):417-24. PubMed ID: 16574716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential experiences of the psychobiological sequelae of ecstasy use: quantitative and qualitative data from an internet study.
    Rodgers J; Buchanan T; Pearson C; Parrott AC; Ling J; Hefferman TM; Scholey AB
    J Psychopharmacol; 2006 May; 20(3):437-46. PubMed ID: 16174668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans.
    Huxster JK; Pirona A; Morgan MJ
    J Psychopharmacol; 2006 Mar; 20(2):281-90. PubMed ID: 16510486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eating attitudes, weight concerns and beliefs about drug effects in women who use ecstasy.
    Curran HV; Robjant K
    J Psychopharmacol; 2006 May; 20(3):425-31. PubMed ID: 16574717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recreational ecstasy use and depression.
    Guillot C; Greenway D
    J Psychopharmacol; 2006 May; 20(3):411-6. PubMed ID: 16574715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study.
    Murphy PN; Wareing M; Fisk J
    J Psychopharmacol; 2006 May; 20(3):447-55. PubMed ID: 16574719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol.
    Indlekofer F; Piechatzek M; Daamen M; Glasmacher C; Lieb R; Pfister H; Tucha O; Lange KW; Wittchen HU; Schütz CG
    J Psychopharmacol; 2009 Jul; 23(5):495-509. PubMed ID: 18635709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The epidemiology of ecstasy use and harms in Australia.
    Degenhardt L; Roxburgh A; Dunn M; Campbell G; Bruno R; Kinner SA; George J; Quinn B; White N; Topp L
    Neuropsychobiology; 2009; 60(3-4):176-87. PubMed ID: 19893334
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metamemory in recreational ecstasy polydrug users: what do self-reports of memory failures mean?
    Bedi G; Redman J
    J Psychopharmacol; 2008 Nov; 22(8):872-81. PubMed ID: 18208933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence, intensity, and assessment of craving for MDMA/ecstasy in recreational users.
    Davis AK; Rosenberg H
    J Psychoactive Drugs; 2014; 46(2):154-61. PubMed ID: 25052792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
    Lyvers M
    Drug Alcohol Rev; 2006 May; 25(3):269-76. PubMed ID: 16753651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in population drug use in New Zealand: findings from national household surveying of drug use in 1998, 2001, 2003, and 2006.
    Wilkins C; Sweetsur P
    N Z Med J; 2008 May; 121(1274):61-71. PubMed ID: 18535647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the acute subjective effects of MDMA/ecstasy.
    Baylen CA; Rosenberg H
    Addiction; 2006 Jul; 101(7):933-47. PubMed ID: 16771886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ecstasy-related deficits in the updating component of executive processes.
    Montgomery C; Fisk JE
    Hum Psychopharmacol; 2008 Aug; 23(6):495-511. PubMed ID: 18512857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extending drug ethno-epidemiology using agent-based modelling.
    Moore D; Dray A; Green R; Hudson SL; Jenkinson R; Siokou C; Perez P; Bammer G; Maher L; Dietze P
    Addiction; 2009 Dec; 104(12):1991-7. PubMed ID: 19804460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
    Kinner SA; Degenhardt L
    Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attributions for psychobiological changes in ecstasy/MDMA and other polydrug users.
    Soar K; Parrott A; Turner J
    J Psychopharmacol; 2009 Sep; 23(7):745-58. PubMed ID: 18635698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.